首页 正文

TAR-200: Investigational intravesical drug delivery system for bladder cancer

{{output}}
Bladder cancer is second among the most common urothelial malignancy and one of the most expensive in terms of treatment. Localized bladder cancer is classified into non-muscle invasive bladder cancer (NMIBC) and muscle invasive bladder cancer (MIBC). First li... ...